Thalassemia Major

What is Thalassemia Major?

Thalassemia major is a severe inherited blood disorder that affects how your body makes hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen throughout your body. People with thalassemia major cannot produce enough healthy hemoglobin, which leads to severe anemia starting in early childhood.

This condition is also called beta-thalassemia major or Cooley's anemia. It happens when you inherit two faulty genes, one from each parent. Without regular treatment, children with thalassemia major cannot survive. The body tries to make red blood cells but they break down too quickly, causing chronic hemolysis. This process releases bilirubin into the bloodstream and puts stress on organs like the liver and spleen.

Thalassemia major is most common in people of Mediterranean, Middle Eastern, South Asian, and African descent. Early diagnosis and lifelong treatment allow people with this condition to live longer, healthier lives. Treatment focuses on managing anemia and preventing complications from iron overload.

Bilirubin, Total

Reveal liver health issues effortlessly
Clarify the cause of jaundice symptoms
Detect bile duct problems early

^$31

Comprehensive Metabolic Profile (includes eGFR)

Reveal underlying health conditions effortlessly
Pinpoint the cause of chronic fatigue
Assess your cardiovascular health comprehensively

^$39

Liver Function Profile

Reveal liver issues before they become serious
Clarify why you're feeling constantly tired
Expose hidden factors affecting your digestion

^$46

Symptoms

Severe fatigue and weakness beginning in infancy
Pale or yellow skin and eyes due to anemia and jaundice
Slow growth and delayed puberty in children
Enlarged spleen and liver
Bone deformities, especially in the face and skull
Dark urine from red blood cell breakdown
Shortness of breath during activity
Frequent infections
Poor appetite

Symptoms typically appear in the first two years of life. Babies may seem healthy at birth but develop severe anemia as fetal hemoglobin is replaced. Without treatment, symptoms worsen rapidly and become life-threatening.

Causes and risk factors

Thalassemia major is caused by inheriting two mutated genes that control hemoglobin production. You receive one gene from your mother and one from your father. When both genes are faulty, your body cannot make the beta chains needed for normal hemoglobin. This genetic mutation is passed down through families and cannot be caused by lifestyle or environmental factors.

Your risk is higher if both parents are carriers of the thalassemia trait. Carriers have one normal gene and one mutated gene, so they usually have no symptoms or mild anemia. When two carriers have children together, each pregnancy has a 25% chance of producing a child with thalassemia major. Genetic counseling helps families understand their risk and make informed decisions about family planning.

How it's diagnosed

Thalassemia major is diagnosed through blood tests that measure hemoglobin levels and identify abnormal red blood cells. A complete blood count shows severe anemia with small, pale red blood cells. Hemoglobin electrophoresis identifies the specific type of abnormal hemoglobin. Genetic testing confirms the diagnosis and identifies the exact mutations.

Regular blood monitoring is essential for people living with thalassemia major. Total bilirubin testing helps track red blood cell breakdown and identify complications like gallstones. Elevated bilirubin occurs because chronic hemolysis releases this yellow pigment into your bloodstream. Rite Aid offers total bilirubin testing as part of our flagship panel, making it easy to monitor this important marker at Quest Diagnostics locations nationwide.

Treatment options

Regular blood transfusions every 2 to 4 weeks to maintain hemoglobin levels
Iron chelation therapy to remove excess iron from transfusions
Folic acid supplements to support red blood cell production
Bone marrow or stem cell transplant, the only potential cure
Spleen removal if the organ becomes too enlarged
Vaccinations to prevent infections
Heart and liver monitoring for iron overload complications
Calcium and vitamin D for bone health
Avoiding iron-rich foods and supplements unless directed by a doctor

Frequently asked questions

Thalassemia major occurs when you inherit two faulty genes and causes severe, life-threatening anemia requiring regular transfusions. Thalassemia minor, also called thalassemia trait, occurs when you inherit one faulty gene and one normal gene. People with thalassemia minor are carriers who usually have no symptoms or only mild anemia that does not require treatment.

Bone marrow transplant or stem cell transplant is currently the only cure for thalassemia major. This treatment replaces faulty blood-forming cells with healthy ones from a matched donor. The procedure carries significant risks and is most successful in young children. Gene therapy is showing promise in clinical trials as a potential future cure.

Most people with thalassemia major need blood transfusions every 2 to 4 weeks to maintain safe hemoglobin levels. The exact frequency depends on how quickly your body breaks down red blood cells and your overall health. Regular transfusions prevent severe anemia and allow people to maintain normal activity levels.

Each blood transfusion adds iron to your body, and humans have no natural way to remove excess iron. Over time, iron accumulates in organs like the heart, liver, and endocrine glands. This buildup can cause organ damage, heart failure, diabetes, and other serious complications. Iron chelation therapy removes excess iron and prevents these problems.

Elevated bilirubin indicates that red blood cells are breaking down faster than normal, a process called hemolysis. When red blood cells die, they release hemoglobin that gets converted to bilirubin. High bilirubin levels can cause yellowing of the skin and eyes. Monitoring bilirubin helps doctors track disease activity and watch for complications like gallstones.

Women with thalassemia major can have successful pregnancies with careful medical management and planning. Pregnancy requires close monitoring by a specialist experienced in high-risk pregnancies and thalassemia care. Complications like heart problems, diabetes, and iron overload must be controlled before conception. Regular transfusions continue throughout pregnancy to support both mother and baby.

People with thalassemia major should limit foods high in iron because they already have iron overload from transfusions. Avoid or minimize red meat, liver, iron-fortified cereals, and dark leafy greens. Do not take vitamin C supplements in large doses, as vitamin C increases iron absorption. Your doctor will provide specific dietary guidance based on your iron levels.

Thalassemia major is typically diagnosed between 6 months and 2 years of age when symptoms first appear. Babies may seem healthy at birth because fetal hemoglobin protects them initially. As fetal hemoglobin is replaced, severe anemia develops and parents notice pale skin, poor feeding, and irritability. Newborn screening programs in some areas allow even earlier diagnosis.

With modern treatment including regular transfusions and iron chelation therapy, many people with thalassemia major live into their 50s, 60s, or beyond. Life expectancy has improved dramatically over the past few decades. The key is strict adherence to treatment and regular monitoring for complications. People who receive bone marrow transplants early in life can have normal life expectancy.

Yes, parents, siblings, and extended family members should consider genetic testing to determine if they carry the thalassemia trait. Knowing your carrier status helps with family planning and understanding risk for future children. Siblings have a 50% chance of being carriers if both parents are carriers. Genetic counseling provides guidance on testing and interpretation of results.